The JULI Registry--Hemp and Cannabis Observational Registry

Description

The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.

Conditions

Chronic Pain, Appetite Disorders, Neuropathy, Menopausal Syndrome, Anxiety, Sleep Disturbance, Nausea

Study Overview

Study Details

Study overview

The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.

The JUvaLIfe Registry

The JULI Registry--Hemp and Cannabis Observational Registry

Condition
Chronic Pain
Intervention / Treatment

-

Contacts and Locations

Los Gatos

Precision Cancer Specialists, Los Gatos, California, United States, 95032

San Jose

Justin Lo MD, San Jose, California, United States, 95128

Nashville

Nashville Breast Center, Nashville, Tennessee, United States, 37203

Dallas

Dallas Surgical Group, Dallas, Texas, United States, 75231

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 21 years of age or older
  • * Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis
  • * Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app.
  • * Patient pregnant
  • * Unwilling or unable to provide informed consent

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Juva Life,

Study Record Dates

2025-02-15